As an essential hub in the ferroptosis regulatory network, FSP1 leverages its unique CoQ10 and VK reductase activities to shield cancer cells from oxidative and ferroptotic damage, thereby fueling tumor progression and treatment resistance across diverse malignancies. This evidence concerns the gene AIFM2 and neoplasm.